Organophosphates{plus 45 degree rule}Nerve Agent Poisoning: Mechanism of Action, Diagnosis, Prophylaxis, And Treatment

Advances in Clinical Chemistry

Volumn 38, Issue , 2004, Pages 151-216

  Bajgar, Jirí ^a  

^a DEPARTMENT OF TOXICOLOGY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ORGANOPHOSPHORUS COMPOUND;

HUMAN; INTOXICATION; REVIEW;

HUMANS; ORGANOPHOSPHORUS COMPOUNDS; POISONING;

EID: 10044275708     PISSN: 00652423     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2423(04)38006-6     Document Type: Article

References (323)

1. M.H. Abernethy P.M. George J.L. Herron R.T. Evans Plasma cholinesterase phenotyping with use of visible-region spectrophotometry Clin. Chem 32 1986 194 197
2. M.B. Abou-Donia Organophosphorus ester-induced delayed neurotoxicity Ann. Rev. Pharmacol. Toxicol 21 1982 511 548
3. M.B. Abou-Donia D.M. Lapadula Mechanisms of organophosphorus ester-induced delayed neurotoxicity: Type I and Type II Ann. Rev. Toxicol 30 1990 405 440
4. W.N. Aldridge Organophosphorus compounds and carbamates, and their reactions with esterases Brit. Med. Bull 25 1969 236 239
5. W.N. Aldridge E. Reiner “Enzyme Inhibitors as Substrates.” 1973 North Holl. Publ. Co Amsterdam-London
6. I. Altrunas N. Delibas M. Demirci I. Kiline N. Tamer The effects of methidathion on lipid peroxidation and some liver enzymes: Role of vitamins E and C Arch. Toxicol 76 2002 470 473
7. R.A. Andersen I. Aaraas G. Gaare F. Fonnum Inhibition of acetylcholinesterase from different species by organophosphorus compounds, carbamates, and methylsulphonylfluoride Gen. Pharmacol 8 1977 331 334
8. D.R. Anderson L.W. Harris F.C.T. Chang W.B. Baze B.R. Capacio S.L. Byers W.J. Lennox Antagonism of soman-induced convulsions by midazolam, diazepam, and scopolamine Drug Chem. Toxicol 20 1997 115 131
9. D.R. Anderson L.W. Harris C.L. Woodard W.I. Lennox The effect of pyridostigmine pretreatment on oxime efficacy against intoxication by soman and VX in rats Drug Chem. Toxicol 15 1992 285 294
10. V. Annapurna I. Senciall A.J. Davis K.M. Kutty Relationship between serum seudocholinesterase and triglycerides in experimentally induced diabetes mellitus in rats Diabetologia 34 1991 320 324
11. B. Antonijevic M.P. Stojiljkovic D. Bokonjic M. Maksimovic M. Nedeljkovic Effect of memantine on the permeability of the mice blood–brain barrier in soman poisoning Toxicol. Lett 144 Suppl. 1 2003 121
12. S.M. Aquilonius T. Fredricksson A. Sundwall Studies on phosphorylated thiocholine and choline derivatives. I. General toxicology and pharmacology Toxicol. Appl. Pharmacol 6 1964 169 179
13. T. Arendt M.K. Bruckner M. Lange V. Bigi Changes in acetycholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development—A study of molecular forms Neurochem. Int 21 1992 381 396
14. Y. Ashani J.O. Peggins B.P. Doctor Mechanism of inhibition of cholinesterases by huperzine A Biochem. Biphys. Res. Commun 184 1992 719 726
15. K.B. Augustinsson Determination of activity of cholinesterases Methods Biochem. Analyt Suppl. 217 1971 217 273
16. D. Aygun Z. Doganay L. Altintop H. Guven M. Onar T. Deniz T. Sunter Serum acetylcholinesterase and prognosis of acute organophosphate poisoning J. Toxicol. Clin Toxicol 40 2002 903 910
17. K. Bachmann Predicting toxicokinetic parameters in humans from toxicokinetic data acquired from three small mammalian species J. Appl. Toxicol 9 1989 331 338
18. J. Bajgar Intoxication with organophosphorus cholinesterase inhibitors. Mechanism of action, diagnosis, and treatment (in Czech) “Novinky v medicine (News in Medicine) 34,” 1985 Avicenum Prague 7 40
19. J. Bajgar Biological monitoring of exposure to nerve agents Brit. J. Ind. Med 49 1992 648 653
20. J. Bajgar Cholinesterases and their possible influencing Voj. Zdrav. Listy 67 1998 1 6
21. J. Bajgar Characterization and properties of multiple molecular forms of acetylcholinesterase. Possible evaluation in histochemistry Acta Histochem Suppl. 15 1975 123 132
22. J. Bajgar Inhibition of acetylcholinesterase in different parts of the brain of mice by isopropyl methylphosphonofluoridate in vitro and in vivo Arch. Toxicol 27 1971 233 241
23. J. Bajgar Inhibition of acetylcholinesterase in different parts of the rat brain by isopropyl methylphosphonofluoridate: In vitro and in vivo experiments Biochem. Pharmacol 22 1972 93 96
24. J. Bajgar Isoenzymes of rat brain acetylcholinesterase: Facts or artifacts? J. Neurochem 32 1979 1875 1879
25. J. Bajgar J. Parizek Changes of acetylcholinesterase and esterase isoenzymes in isolated cerebellar cortex of the rabbit Brain. Res 57 1973 299 305
26. J. Bajgar Present views on toxidynamics of soman poisoning Acta Med. (Hradec Kralove) 39 1996 101 105
27. J. Bajgar The influence of inhibitors and other factors on cholinesterases Sbor. Ved. Pr. LFUK (Hradec Kralove) 34 1991 3 75
28. J. Bajgar Time course of acetylcholinesterase inhibition in the medulla oblongata of the rat by O-ethyl S-(2dimethylaminoethyl) methylphonothioate in vivo Brit. J. Pharmacol 45 1972 368 371
29. J. Bajgar Differential inhibition of the brain acetylcholinesterase molecular forms following soman, sarin, and VX intoxication in laboratory rats Acta Medica (Hradec Kralove) 40 1997 89 94
30. J. Bajgar J. Fusek J. Kassa J. Vachek Relationship between toxicity and in vivo anticholinesterase potency in nerve agent poisoning Voj. Zdrav. Listy 70 2001 18 20
31. J. Bajgar J. Fusek J. Patocka V. Hrdina Protective effect of 9-amino-7-methoxy-1,2,3,4-tetrahydroacridine against O-ethyl S-(2-dimethylaminoethyl) methylphosphono-thioate in vivo Arch. Toxicol 54 1983 163 166
32. J. Bajgar J. Fusek J. Vachek Treatment and prophylaxis against nerve agent poisoning ASA Newsletter 94–4 1994 10 11
33. J. Bajgar J. Fusek J. Vachek J. Kassa J. Patocka Organophosphate poisoning: Improvement of prophylaxis “Proceedings of the 2nd CB Medical Treatment Symposium, 7–12 July 1996,” 1996 201 204 Spiez Switzerland
34. J. Bajgar J. Hak Acetylcholinesterase activity and its molecular forms in rectal tissue in the diagnosis of Hirschprung's disease Clin. Chim. Acta 93 1979 93 95
35. J. Bajgar A. Jakl V. Hrdina Influence of trimedoxime and atropine on acetylcholinesterase activity in some parts of the brain of mice poisoned by isopropylmethyl phosphonofluoridate Biochem. Pharmacol 20 1971 3230 3233
36. J. Bajgar A. Jakl V. Hrdina The influence of obidoxime on acetylcholinesterase activity following isopropyl methylphosphonofluoridate intoxication Eur. J. Pharmacol 19 1972 199 202
37. J. Bajgar J. Kassa J. Fusek Diagnostic validity of different biochemical parameters following organophosphate poisoning “Proceedings from the 6th CBW Protection Symposium, Stockholm, Sweden, May 10–15, 1998,” 1998 185 188
38. J. Bajgar H. Michalek G.M. Bisso Differential inhibition of rat brain acetylcholinesterase molecular forms by 7-methoxytacrine in vitro Toxicol. Lett 80 1995 109 114
39. J. Bajgar H. Michalek G.M. Bisso Differential reactivation by HI-6 in vivo of Paraoxon-inhibited rat brain acetylcholinesterase molecular forms Neurochem. Int 26 1995 347 350
40. J. Bajgar J. Patocka A. Jakl V. Hrdina Antidotal therapy and changes of acetylcholinesterase activity following isopropyl methylphosphonofluoridate in mice Acta Biol. Med. Germ 34 1975 1049 1055
41. J. Bajgar R. Portmann The treatment of intoxication with selected organophosphates and carbamate: Comparison of different therapeutic approaches “Proceedings CBMTS—Industry II, The First Congress on Chemical and Biological Terrorism, Dubrovnik 21–27, April 2001,” 2001 180 184
42. J. Bajgar V. Zizkovsky Partial characterization of soluble acetylcholinesterase isoenzymes of the rat brain J. Neurochem 18 1971 1609 1614
43. P.G. Bardin S.F. van Eeden Organophosphate poisoning: Grading the severity and comparing treatment between atropine and glycopyrrolate Crit. Care Med 18 1990 956 960
44. P.G. Bardin S.F. van Eeden J.R. Joubert Intensive care management of acute organophosphate poisoning: A 7-year experience in the Western Cape S. Afr. Med. J 72 1987 593 597
45. P.G. Bardin S.F. van Eeden J.A. Moolman A.P. Foden J.R. Joubert Organophosphate and carbamate poisoning Arch. Intern. Med 154 1994 1433 1441
46. H.P. Benschop L.P.A. de Jong Toxicokinetics of nerve agents Voj. Zdrav. Listy 70 2001 2 12
47. H.P. Benschop L.P.A. de Jong Toxicokinetics of nerve agents S.M. Somani J.A. Romano “Chemical Warfare Agents: Toxicity at Low Levels” 2001 CRC Press Boca Raton, FL 25 81
48. F. Berends Mechanisms of aging of organophosphate-inhibited esterases F. de Matteis E.A. Lock “Selectivity and Molecular Mechanisms of Toxicity” 1987 McMillan Press London, UK 125 152
49. G. Bignami M. Rosic H. Michalek M. Milosevic G.L. Gatti Behavioral toxicity of anticholinesterase agents: Methodological, neurobiochemical, and neurophysiological aspects B. Weiss V.G Laties “Behavioral Toxicology” 1975 Plenum Publ. Corp New York 155 215
50. J.R. Bonham J.R. Attack A neural tube defect specific form of acetylcholinesterase in amniotic fluid Clin. Chim. Acta 135 1983 233 237
51. S. Brimijoin Z. Rakonczay Immunocytology and molecular histology of cholinesterases: Current results and prospects Int. Rev. Neurobiol 28 1986 353 410
52. C.A. Broomfield O. Lockridge C.B. Millard D.E. Lenz Design and construction of butyrylcholinesterase mutants that have organophosphorus acid anhydride hydrolase activity “m-CB Medical Treatment Symposium, Hradec Kralove, 26–30 May 1997,” 1997 13 14 [Abstracts].
53. M.A. Brown A.B. Kelley Review of health consequences from high-, intermediate-, and low-level exposure to organophosphorus nerve agents J. Appl. Toxicol 18 1998 393 408
54. S.S. Brown W. Kalow W. Pilz M. Whittaker C.L. Woronick The plasma cholinesterases: A new perspective Adv. Clin. Chem 22 1981 1 123
55. R.H. Brownson H.D. Mc Dougal B.D. Suter V.K. Vijayan Parathion-induced alterations in chemical, biochemical, and isoenzyme study L. Roizin H. Shirachi N. Grcevic “Neurotoxicology” 1987 Raven Press New York 457 468
56. J.J. Buccafusco J.H. Graham J. VanLingen R.S. Aronstam Protection afforded by clonidine from the acute and chronic behavioral toxicity produced by the cholinesterase inhibitor soman Neurotoxicol Teratol 11 1989 39 44
57. T. Burt Donepezil and related cholinesterase inhibitors as mood and behavioral controlling agents Curr. Psychiat. Rep 2 2000 473 478
58. R.W. Busker J.J. Zijlstra H.J. van der Wiel H.P.M. Helden The functional role of molecular forms of acetylcholinesterase in neuromuscular transmission Neurochem. Res 19 1994 713 719
59. J.G. Cannon M.F. Sahin R.K. Bhatnagar J.R. Flynn J.P. Long Structure-activity studies on a potent antagonist to organophosphate-induced toxicity J. Med. Chem 34 1991 1582 1584
60. B.R. Capacio T.-M. Shih Anticonvulsant actions of anticholinergic drugs in soman poisoning Epilepsia 32 2001 604 615
61. M.G. Clark A. Saxena S.M. Anderson W. Sun R. Bansal T.M. Myers B.P. Doctor Behavioral toxicity of purified human serum butyrylcholinesterase in mice “The 4th International CB Medical Treatment Symposium, 28 April–3 May 2002, Spiez, Switzerland,” 2002 [Abstract No 19].
62. J.G. Clement Survivors of soman poisoning: Recovery of the soman LD50 to control value in the presence of extensive acetylcholinesterase inhibition Arch Toxicol 63 1989 150 154
63. J.G. Clement Toxicity of the combined nerve agents GB⧸GF in mice: Efficacy of atropine and various oximes as antidotes Arch. Toxicol 68 1994 64 66
64. J.G. Clement B.T. Hand J.D. Shilhoff Differences in the toxicity of soman in various strains of mice Fund. Appl. Toxicol 1 1981 419 420
65. D.B. Coult D.J. Marsh G. Read Dealkylation studies on inhibited acetylcholinesterase Biochem. J 98 1966 869 873
66. F.M. Cowan T.M. Shih D.E. Lenz J.M. Madsen C.A. Broomfield Hypothesis for synergistic toxicity of organophosphorus poisoning-induced cholinergic crisis and anaphylactoid reactions J. Appl. Toxicol 16 1996 25 33
67. C. Cremisini S. Sario J. Mela R. Pilloton G. Palleschi Evaluation of the use of free and immobilized acetylcholinesterase for paraoxon detection with an amperometric choline oxidase based biosensor Analyt Chim. Acta 311 1995 273 280
68. G.D. D'Mello F.R. Sidell A model for carbamate and organophosphate-induced emesis in humans Neurosci. Behav. Rev 15 1991 179 184
69. N.C. Danbolt Glutamate uptake Progr. Neurobiol 65 2001 1 105
70. S. Darvesh D.A. Hopkins C. Geula Neurobiology of butyrylcholinesterase Nature Rev. Neurosci 4 2003 131 138
71. S. Darvesh R. Walsh R. Kumar A. Caines S. Roberts D. Magee K. Rockwood E. Martin Inhibition of human cholinesterases by drugs used to treat Alzheimer's disease Alzheimer Dis. Assoc. Disord 17 2003 117 126
72. S. Das Gupta In vitro assessment of antidotes to organophosphorus toxicity Arch. Toxicol Suppl. 14 1991 3 7
73. J.E. Davies A. Barquet W.H. Freed Human pesticide poisoning by a fat-soluble organophosphate insecticide Arch. Environ. Health 30 1975 608 613
74. R.M. Dawson Review of oximes available for the treatment of nerve agent poisoning J. Appl. Toxicol 14 1994 317 331
75. H.C. De Bisschop W.A.P. de Meerleer J.L. Willems Stereoselective phosphonylation of human serum proteins by soman Biochem. Pharmacol 36 1987 3587 3591
76. J. De Bleecker D. Lison K. van den Abeele J. Willems J. de Reuck Acute and subacute organophosphate poisoning in the rat Neurotoxicology 15 1994 341 348
77. J.L. De Bleecker J.L. de Reuck J.L. Willems Neurological aspects of organophosphate poisoning Clin. Neurol Neurosurg 94 1992 93 103
78. L.P. De Jong C. van Dijk Formation of soman (1,2,2-trimethylpropyl methylphosphonofluoridate) via fluoride-induced reactivation of soman-inhibited aliesterase in rat plasma Biochem. Pharmacol 33 1984 663 669
79. L.P.A. De Jong H.P. Benschop Biochemical and toxicological implications of chirality in anticholinesterase organophosphate E.J. Ariens J.J.S. van Rensen W. Welling “Chemicals in Agriculture. VO1 Stereoselectivity of Pesticides. Biological and Chemical Problems” 1988 Elsevier Amsterdam, Oxford, New York, Tokyo 109 149
80. L.P.A. De Jong H.P. Benschop G.R. van den Berg G.Z. Wolring D. de Korte Reactivation of tabun-inhibited acetylcholinesterase by 1-(hetero) arylmethyl-pyridinium-oximes Eur. J. Med. Chem. (Chim. Therapeut.) 15 1981 257 262
81. L.P.A. De Jong S.P. Kossen Stereospecific reactivation of human brain and erythrocyte acetylcholinesterase inhibited by 1,2,2-trimethylpropyl methylphosphono-fluoridate (soman) Biochim. Biophys. Acta 830 1985 345 348
82. L.P.A. De Jong G.Z. Wolring Effect of 1-(ar)alkyl-2-hydroxyiminomethyl-pyridinium salts on reactivation and aging of acetylcholinesterase inhibited by ethyl dimethylphosphoramidocyanidate (Tabun) Biochem. Pharmacol 27 1978 2229 2235
83. B.P. Doctor D.M. Maxwell A. Saxena Preparation and characterization of bioscavengers for possible use against organophosphate toxicity “m-CB Medical Treatment Symposium, 26–30 May 1997, Hradec Kralove,” 1997 17 18 [Abstracts p].
84. B.P. Doctor L. Raveh A.D. Wolfe D.M. Maxwell Y. Ashani Enzymes as pretreatment drugs for organophosphate toxicity Neurosci. Behav. Rev 15 1991 123 128
85. B.P. Doctor A. Saxena M.G. Clark R. Bansal C. Luo Y. Rosenberg D. Lenz Y. Ashani Scavenger protection against organophosphates by human serum butyrylcholinesterase “The 4th International CB Medical Treatment Symposium, 28 April–3 May 2002, Spiez, Switzerland,” 2002 [Abstract No 24].
86. P. Dolezal J. Vachek A. Hrabalek In vitro transdermal permeation of a cholinesterase reactivator HI-6 R.K. Brain K.A. Walters “Perspectives in Percutaneous Penetration” Vol. 6A 1988 STS Publishing Cardiff 84
87. G. Domjan J. Jako I. Valyi-Nagy Determination of cholinesterase in human blood using near infrared spectroscopy J. Near Infrared Spectrosc 6 1998 279 284
88. P.W. Du Toit F.O. Muller W.M. van Tonder Experience with the intensive care management of organophosphate insecticide poisoning S. Afr. Med. J 60 1981 227 229
89. M. Eddleston L. Szinicz P. Eyer N. Beuckley Oximes in acute organophosphorus pesticide poisoning: A systematic review of clinical trials QJM Monthly J. Assoc. Phys 95 2002 275 283
90. G.L. Ellman D.K. Courtney V. Andres R.M. Featherstone A new and rapid colorimetric determination of acetylcholinesterase activity Biochem. Pharmacol 7 1961 88 95
91. W.D. Erdmann H. Engelhad Pharmakologisch-toxikologische Untersuchungen mit dem Dichlorid des Bis-(4-hydroxyiminomethyl-pyridinium-1-methyläthers) einem neuen Estrerase Reaktivator Arzeneim. Forsch 14 1964 5 11
92. A. Falb W.D. Erdmann Über die Paermeation von 14C-obidoxim durch die sog. Blut-Hirnschranke von Mausen und Rate Arch. Toxicol 24 1969 123 132
93. C. Fest K.-J. Schmidt The chemistry of organophosphorus pesticides Second revised edition 1982 Springer-Verlag Berlin, Heidelberg, New York
94. A. Fidder A.G. Hulst D. Noort R. de Ruiter M.J. van der Schans H.P. Benschop J.P. Langenberg Retrospective detection of exposure to organophosphorus anti-cholinesterases: Mass spectrometric analysis of phosphylated human butyrylcholinesterase Chem. Res. Toxicol 15 2002 582 590
95. V. Fiserova-Bergerova Polarografische Bestimmung der Cholinesterase-und Azetylcholinesterase-Aktivitat. Kinetische Daten der enzymatischen Analysis Coll. Czechoslov. Chem. Commun 28 1969 3311 3325
96. J.H. Fleisher L.W. Harris Dealkylation as a mechanism for aging for cholinesterase after poisoning with pinacolyl methylphosphonofluoridate Biochem. Pharmacol 14 1965 641 650
97. S.E. Freeman R.M. Dawson Tacrine: A pharmacological review Prog. Neurobiol 36 1991 257 277
98. J. Fusek Tacrin and its analogues, antidotes against psychotomimetics with anticholinergic effect (in Czech) Voj. Zdrav. Listy 46 1977 21 27
99. J. Fusek J. Bajgar J. Vachek The prophylactic antidote against nerve paralytic agents—PANPAL The Meeting of NATO TG 004 Task Group on Prophylaxis and Therapy of Chemical Agents, 11–13 September 2000, The Hague, The Netherlands 2000
100. A. Galli A. Mazri Protection against diisopropylfluorophosphate intoxication by Meptazinol Toxicol. Appl. Pharmacol 95 1988 388 396
101. M.K. Gentry P.B. Doctor Alignment of amino acid sequences of acetylcholinesterases and butyrylcholinesterases J. Massculié F. Bacou E. Barnard A. Charonnet B.P. Doctor D.M. Cuinn “Cholinesterases: Structure, Function, Mechanism, Genetics, and Cell Biology” 1991 American Chemical Society 394 398
102. E. Gilat M. Goldman E. Lahat A. Levy I. Rabinovitz G. Cohen R. Brandeis G. Amitai D. Alkalai G. Eshel Nasal midazolam as a novel anticonvulsive treatment against organophosphate-induced seizure activity in the guinea pig Arch. Toxicol 77 2003 167 172
103. P. Gopalakrishnakone Microarray analysis of the human brain cell lines following exposure to a chemical agent, soman K. Laihia “Symposium Proceedings NBC 2003” 2003 Javaskyla Finland 146 147
104. A.P. Gray Design and structure-activity relationships of antidotes to organophosphorus anticholinesterase agents Drug Metab. Rev 15 1984 557 589
105. A.L. Green A theoretical kinetic analysis of the protective action exerted by eserine and other carbamate anticholinesterase against poisoning by organophosphorus compounds Biochem. Pharmacol 32 1983 1717 1722
106. A.L. Green The kinetic basis of organophosphate poisoning and its treatment Biochem. Pharmacol 1 1958 115 128
107. Z. Grubic A. Tomazic Mechanism of action of HI-6 on soman inhibition of acetylcholinesterase of rat and human skeletal muscle: Comparison to SAD-128 and PAM-2 Arch. Toxicol 63 1989 68 71
108. J. Grunwald L. Raveh B.P. Doctor Y. Ashani Huperzine A as a pretreatment candidate drug against nerve agent toxicity Life Sci 54 1994 991 997
109. R.C. Gupta D. Milatovic W.D. Dettbarn Depletion of energy metabolites following acetylcholinesterase inhibitor-induced status epilepticus: Protection by antioxidants Neurotoxicology 22 2001 271 282
110. V. Hadacova E. Klozova K. Pitterova V. Turkova The screening of the enzyme and isoenzyme patterns in seeds of Alium cepa cultivar Vsetatska Biol. Plant (Prague) 23 1981 442 448
111. M. Harel J.L. Sussmann E. Krejci Conversion of acetylcholinesterase to buryrylcholinesterase: Modeling and mutagenesis Proc. Natl Acad. Sci. USA 89 1992 10827 10831
112. G.J. Harry M. Billingsley A. Bruinink I.L. Campbell W. Classen D.C. Dorman C. Galli D. Ray R.A. Smith H.A. Tilson In vitro assessment for the assessment of neurotoxicity Environ. Health Perspect 106 Suppl. 1 1998 131 158
113. B. Hassel N. Nguyen A. Brathe Brain energy metabolism and soman intoxication The meeting of NATO TG 004 Task Group on Prophylaxis and Therapy of Chemical Agents. 4–7 November 2002, Oslo, Norway 2002
114. D.F. Heath Organophosphorus poisons. Anticholinesterases and related compounds P. Alexander Z.M. Bacq “Modern Trends in Physiological Sciences” 1961 Pergamon Press Oxford, London, New York, Paris
115. J. Herink Experimental study of some functional and pharmacological properties of cholinoreactive structures of the septum (in Czech). Thesis, Doctor's dissertation work, Hradec Kralove, Military Medical Academy, p 251 1992
116. J. Herink J. Bajgar V. Hrdina Participation of cholinergic mechanisms in the propagation of after-discharges in the limbic system Electroencephalogr. Clin. Neurophysiol 48 1980 56 57
117. J. Herink J. Bajgar J. Patocka Changes of acetylcholinesterase activity in some parts of the limbic system following septal lesions in rats J. Neurochem 25 1975 187 188
118. J. Herink M. Koupilova J. Bajgar Effect of triazolam on convulsions induced by pentylentetrazol Homeostasis 33 1991 181
119. J. Herink M. Koupilova V. Hrdina Effect of alprazolam on pentylentetrazol convulsions Activ. Nerv. Sup. (Prague) 32 1990 297 298
120. S. Hestrin The reaction of acetylcholine and other carboxylic acid derivatives with hydroxylamine, and its analytical application J. Biol. Chem 180 1949 241 249
121. F. Hobbiger Z. Vojvodic The reactivation by pyridinium aldoximes of phosphorylated acetylcholinesterase in the central nervous system Biochem. Pharmacol 16 1967 455 462
122. B. Holmstedt Distribution and determination of cholinesterases in mammals Bull. WHO 44 1971 99 107
123. R.H. Inns L. Leadbeater The efficacy of bispyridinium derivates in the treatment of organophosphonate poisoning in the guinea-pig J. Pharm. Pharmacol 35 1983 427 433
124. M. Israel B. Lesbats The use of bioluminescence techniques in neurobiology with emphasis to the cholinergic system A.J. Turne H.S. Bachelard “Neurochemistry: A Practical Approach” 1987 IRL Press Washington 113 125
125. J. Jeyaratnam Pesticides poisoning as a global health problem World Health Stat. Q 43 1990 139 144
126. M.K. Johnson Contemporary issues in toxicology, organophosphate, and delayed neuropathy—Is NTE alive and well? Toxicol. Appl. Pharmacol 102 1990 385 399
127. M.K. Johnson Molecular events in delayed neuropathy: Experimental aspects of neuropathy target esterase B. Ballantyne T.C. Marrs “Clinical and Experimental Toxicology of Organophosphates and Carbamates” 1992 Butterworth-Heinemann Ltd Oxford 90 113
128. M.K. Johnson P. Glinn Neuropathy target esterase (NTE) and organophosphorus-induced delayed polyneuropathy (OPIDP): Recent advances Toxicol. Lett 82⧸83 1995 459 463
129. M. Jokanovic Liver esterases and soman toxicity in the rat following partial hepatectomy Biochem Pharmacol 39 1990 797 799
130. T. Kadar L. Raveh G. Cohen N. Oz I. Baraness A. Balan Y. Ashani S. Shapira Distribution of 3H-soman in mice Arch. Toxicol. L 58 1985 45 49
131. E. Kaliste-Korhonen R. Ryhanen P. Ylitalo O. Hanninen Cold exposure decreases the effectiveness of atropine-oxime treatment in organophosphate intoxication in rats and mice Gen. Pharmacol 20 1989 805 809
132. S. Kalkan A. Erdogan O. Aygoren S. Capar Y. Tuncok Pesticide poisonings reported to the drug and poison information center in Izmir, Turkey Vet. Hum. Toxicol 45 2003 50 52
133. B.M. Karlsson M. Koch L.O.D. Koskinen Effects of soman in animals pretreated with nimodipine “Proceedings from 6th CBW Protection Symposium, Stockholm, May 10–15, 1998,” 1998 181 184
134. J. Kassa Comparison of efficacy of two oximes (HI-6 and obidoxime) in soman poisoning in rats Toxicology 101 1995 167 174
135. J. Kassa Non-specific effects of organophosphorus inhibitors of cholinesterases Voj. Zdrav. Listy 67 1998 15 19
136. J. Kassa Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents J. Toxicol. Clin. Toxicol 6 2002 803 816
137. J. Kassa J. Bajgar The influence of pharmacological pretreatment on efficacy of HI-6 oxime in combination with benactyzine in soman poisoning in rats Hum. Exp. Toxicol 15 1996 383 388
138. J. Kassa J. Cabal A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with currently available oximes and H oximes against soman in vitro and in vivo methods Toxicology 132 1999 111 118
139. J. Kassa J. Cabal A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with presently used oximes and H oximes against sarin by in vitro and in vivo methods Hum. Exp. Toxicol 81 1999 560 565
140. J. Kassa J. Cabal A comparison of the efficacy of acetylcholinesterase reactivators against cyclohexyl methylphosphonofluoridate (GF agent) by in vitro and in vivo methods Pharmacol. Toxicol 84 1999 41 45
141. J. Kassa J. Cabal J. Bajgar L. Szinicz The choice: HI-6, pralidoxime, or obidoxime against nerve agents? ASA Newslett 97–4 1997 16 18
142. J. Kassa K. Frankova P. Hoder J. Patocka A comparison of the efficacy of cholinolytics atropine and biperiden (Akineton) in combination with HI-6 on cholinergic and stressogenic effects of soman in rats Homeostasis 37 1996 135 136
143. J. Kassa J. Fusek The influence of anticholinergic drug selection on the efficacy of antidotal treatment of soman poisoned rats Toxicology 154 2000 67 73
144. J. Kassa J. Fusek The positive influence of a cholinergic–anticholinergic pretreatment and antidotal treatment on rats poisoned with supralethal doses of soman Toxicology 128 1998 1 7
145. J. Kassa J. Fusek J. Bajgar The importance of PANPAL pretreatment for survival of rats poisoned with supralethal dose of soman “m-CB Medical Treatment Symposium, 26–30 May 1997, Hradec Kralove,” 1997 21 22 [Abstracts].
146. J. Kassa M. Pecka M. Tichy J. Bajgar M. Koupilova J. Herink Z. Krocova Toxic effect of sarin in rats at three months following single or repeated low-level inhalation exposure Pharmacol. Toxicol 88 2001 209 212
147. J. Kassa J. Vachek A comparison of the efficacy of pyridostigmine alone and in the combination of pyridostigmine with anticholinergic drugs as pharmacological pretreatment of tabun-poisoned rats and mice Toxicology 177 2002 179 185
148. J. Kassa J. Vachek J. Bajgar J. Fusek A combination of pyridostigmine with anticholinergic drugs: Effective pharmacological pretreatment of soman-poisoned mice ASA Newslett 84 2001 16 19
149. J. Kassa J. Vachek J. Bajgar J. Fusek A comparison of the efficacy of pharmacological pretreatments against soman in mice Voj. Zdrav. Listy 70 Suppl. 2001 22 25
150. S. Khan R. Hemalatha L. Jeyaseelan A. Oomen A. Zachariah Neuroparalysis and oxime efficacy in organophosphate poisoning: A study of butyrylcholinesterase Human Exp. Toxicol 20 2001 169 174
151. O.A. Khodakovskaya N.A. Vodolazskaya L.D. Glukhova S.I. Timofeeva A.S. Polezina S.I. Dvoretskaya E.I. Malochina I.N. Golubev Early diagnostics of delayed neurotoxicity Toxicol. Lett 144 Suppl. 1 2003 133
152. D. Kiderlen F. Worek R. Klimmek P. Eyer The phosphoryl oxime-destroying activity in human plasma Arch. Toxicol 74 2000 27 32
153. Y.B. Kim K.C. Cheon G.H. Hur T.S. Phi S.J. Choi D. Hong J.K. Kang Effects of combinational prophylactics composed of physostigmine and procyclidine on soman-induced lethality, seizures, and brain injuries Env. Toxicol. Pharmacol 11 2002 15 21
154. Y.B. Kim K.C. Cheon G.H. Hur T.S. Phi G.B. Yeon Prophylactic effect of physostigmine and procyclidine against nerve-agent poisoning “Seventh International Symposium on Protection against CBWA. Stockholm, Sweden, 15–19 June 2001,” 2001 158 [Abstracts].
155. H. Kobayashi Z. Li A. Yamataka G.J. Lane H. Yokota A. Watanabe T. Miyano Acetylcholinesterase distribution and refractory constipation—A new criterion for diagnosis and management Pediatr. Surg. Int 18 2002 349 353
156. G.B. Koelle (Sub-Editor) Handbuch der experimentellen Pharmakologie. Cholinesterases and anticholinesterase agents. 15. Band 1963 Springer-Verlag Berlin, Gottingen, Heidelberg
157. G.B. Koelle Protection of cholinesterase against irreversible inactivation by DFP in vitro J. Pharmacol. Exp. Therap 88 1946 323 327
158. J. Konickova T. Wadso Use of flow microcalorimetry for the determination of cholinesterase activity and its inhibition by organophosphorus pesticides Acta Chem. Scand 25 1971 2360 2382
159. I. Koplovitz Alternative oximes for treatment of nerve agent poisoning The meeting of NATO TG 004 Task Group on Prophylaxis and Therapy of Chemical Agents, 4–7 November, Oslo, Norway 2002
160. I. Koplovitz J.R. Stewart A comparison of the efficacy of HI-6 and 2-PAM against soman, tabun, sarin, and VX in the rabbit Toxicol. Lett 70 1994 269 279
161. I. Koplovitz V.C. Gresham L.W. Dochterman A. Kaminskis J.R. Stewart Evaluation of the toxicity, pathology, and treatment of cyclohexylmethyl-phosphonofluoridate (CMPF) poisoning in rhesus monkeys Arch. Toxicol 66 1994 622 628
162. I. Koplovitz L.W. Harris D.R. Anderson W.J. Lennox J.R. Stewart Reduction by pyridostigmine pretreatment of the efficacy of atropine and 2-PAM treatment of sarin and VX poisoning in rodents Fundam. Appl. Toxicol 18 1992 192–106
163. I. Koplovitz S. Schulz M. Shutz R. Railer R. Macalalag M. Schons J. McDonough Combined anticonvulsant treatment of soman-induced seizure J. Appl. Toxicol 21 2001 S53 S55
164. H. Koponen P.J. Riekkinen Cerebrospinal fluid acetylcholinesterase in patients with dementia associated with schizophrenia or chronic alcoholism Acta Psychiat. Scand 83 1991 441 443
165. R. Koster Synergisms and antagonisms between physostigmine and diisopropyl fluorophosphate in cats J. Pharmacol. Exp. Therap 88 1946 39 46
166. M. Koupilova J. Kassa The influence of Panpal pretreatment on the elimination of soman-induced neurotoxicity by antidotes in rats Homeostasis 39 1999 133 135
167. V. Kovacevic M. Maksimovic Protective effects of mixture of oximes in poisoning by nerve chemical warfare agents Acta Pharm. Yugoslav 41 1991 75 78
168. G. Krejcova J. Kassa Neuroprotective efficacy of pharmacological pretreatment and antidotal treatment in tabun-poisoned rats Toxicology 185 2003 129 139
169. H. Kubova J. Herink P. Mares Effects of clonazepam on epileptic activity induced by local application of atropine into the septum Activ. Nerv. Sup. (Prague) 32 1990 211
170. K. Kuca J. Bielavsky J. Cabal M. Bielavska Synthesis of a potential reactivator of acetylcholinesterase—1-(4-hydroxyiminomethylpyridinium)-3-(carbamoylpyridinium) propane bromide Tetrahedron Lett 44 2003 3123 3125
171. K. Kuca J. Bielavsky J. Cabal J. Kassa Synthesis of a new reactivator of tabun-inhibited acetylcholinesterase Bioorg. Med. Chem. Lett 13 2003 3545 3547
172. K. Kuca J. Kassa A comparison of the ability of a new bispyridinium oxime —1-(hydroxyiminomethylpyridinium)-4-(carbamoylpyridinium)butane dibromide—and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods J. Enzyme Inhib. Med. Chem 18 2003 529 535
173. K. Kuca J. Patocka J. Cabal Reactivation of organophosphate-inhibited acetylcholinesterase activity by alpha, omega-bis-(4-hydroxyiminomethylpyridinium) alkanes in vitro J. Appl. Biomed 1 2003 207 211
174. F. Kusu T. Tsuneta K. Takamura Fluorimetric determination of pseudo-cholinesterase activity in postmortem blood samples J. For. Sci 35 1990 1330 1334
175. K.M. Kutty Biological function of cholinesterase Clin. Biochem 13 1980 239 243
176. G. Lallement V. Baille D. Baubichon P. Carpentier J.M. Collombet P. Filliat A. Foquin E. Four C. Masqueliez G. Testylier L. Tonduli F. Dorandeu Review of the value of huperzine as pretreatment of organophosphate poisoning Neurotoxicology 23 2002 1 5
177. G. Lallement D. Clarencon G. Brochier D. Baubichon M. Galonnier G. Blanchet J.-C. Mestries Efficacy of atropine⧸pralidoxime⧸diazepam or atropine⧸HI-6⧸prodiazepam in primates intoxicated by soman Pharmacol. Biochem. Behav 56 1997 326 332
178. W.M. Lau Protection by Tacrine and atropine against the depressant effects of soman in guinea pig atrium “Proceedings 4th International Symposium Protection Against Chemical Warfare Agents, Stockholm, 8–12 June 1992,” (Suppl.) 1992 182
179. R. Lederer J. Elsner G. Zbinden Animal models in behavioral toxicology and teratology Arch. Toxicol Suppl.14 1991 15 24
180. K.P. Lehre B. Hassel The role of glutamate transporters in soman poisoning. The meeting of NATO TG 004 Task Group on Prophylaxis and Therapy of Chemical Agents. 4–7 November 2002, Oslo, Norway 2002
181. D.E. Lenz D.M. Maxwell Inhibition of rat cerebrum acetylcholinesterase isoenzymes after acute administration of soman Biochem. Pharmacol 30 1981 1369 1371
182. D.E. Lenz A.A. Broomfield L.A. Cook The development of immunoassays for detection of chemical warfare agents “m-CB Medical Treatment Symposium, 26–30 May 1997, Hradec Kralove,” 1997 22 23 [Abstracts].
183. D.E. Lenz A.A. Broomfield L.A. Cook Development of immunoassay for detection of chemical warfare agents Immunochem. Technol. Environ. Applic. ACS Symp. Series 657 1997 77 86
184. A. Levy R. Brandeis Y. Meshulam S. Shapira D. Levy Human studies with transdermal physostigmine “Proceedigs 4th International Symposium Protection Against Chemical Warfare Agents, Stockholm, 8–12 June 1992,” 1992 277 284
185. W.F. Li C.E. Furlong L.G. Costa Paraoxonase protects against chlorpyrifos toxicity in mice Toxicol. Lett 76 1995 219 226
186. P.J. Little J.A. Scimeca B.R. Martin Distribution of ⧸H3⧸diisopropylfluorophosphate, ⧸H3⧸soman, ⧸H3⧸sarin, and their metabolites in mouse brain Drug Metab. Disp 16 1988 515 520
187. W.-F. Liu A symptomatological assessment of organophosphate-induced lethality in mice: Comparison of atropine and clonidine protection Toxicol. Lett 56 1991 19 32
188. O. Lockridge P. Masson Pesticide and susceptible populations: People with butyrylcholinesterase genetic variants may be at risk Neurotoxicology 21 2000 113 126
189. W.K. Loke E. Chua H.P. Loo S.H. Tan C. Teo Anticonvulsant effects of post-intoxication administered atropine–clonidine drug combination in soman-poisoned rats “Seventh International Symposium on Protection against CBWA. Stockholm, 15–19 June 2001,” 2001 160 [Abstracts].
190. M. Lotti Organophosphorus compounds P.S. Spencer H.H. Schaumburg “Experimental and Clinical Neurotoxicology,” 2nd ed. 2000 Oxford University Press New York 898 925
191. M. Lotti The pathogenesis of organophosphate polyneuropathy Crit. Rev. Toxicol 21 1992 465 487
192. M. Lotti A. Moretto Promotion of organophosphate-induced delayed polyneuropathy by certain esterase inhibotors Chem. Biol. Interact 119–120 1999 519 524
193. C.Y. Luo H. Leader Z. Radic D.M. Maxwell P. Taylor B.P. Doctor A. Saxena Two possible orientations of the HI-6 molecule in the reactivation of organophosphate-inhibited acetylcholinesterase Biochem. Pharmacol 66 2003 387 392
194. T.C. Marrs Organophosphate poisoning Pharmac. Ther 58 1993 51 66
195. T.C. Marrs R.L. Maynard F.R. Sidell “Chemical Warfare Agents. Toxicology and Treatment.” 1996 J. Wiley and Sons Chicester, New York, Brisbane, Toronto, Singapore
196. J. Masopust Clinical biochemistry of biliary ducts Part 2. (Tests for bile production and excretion, proteosynthesis, and detoxification) (in Czech) Biochem. Clin. Bohemoslov 12 1983 363 376
197. P. Masson F. Nachon O. Lockridge Crystal structure of human butyrylcholinesterase: A key step for engeneering of catalytic scavengers against organophosphate poisoning Voj. Zdrav. Listy 70 2001 13
198. J. Massoulié The origin of the molecular diversity and functional anchoring of cholinesterases Neurosignals 11 2002 130 143
199. J. Massoulié S. Bon The molecular forms of cholinesterase and acetylcholinesterase in vertebrates Ann. Rev. Neurosci 5 1982 57 106
200. J. Massoulié L. Pezzementi S. Bon E. Krejci F.M. Vallette Molecular and cellular biology of cholinesterases Progr. Neurobiol 41 1993 31 91
201. D.M. Maxwell K.M. Brecht The role of carboxylesterase in species variation of oxime protection against soman Neurosci. Biobehav. Rev 15 1991 135 139
202. D.M. Maxwell K. Brecht A. Saxena S. Feaster B.P. Doctor Comparison of cholinesterases and carboxylesterase as bioscavengers for organophosphorus compounds B.P. Doctor “Structure and Function of Cholinesterases and Related Proteins” 1998 Plenum Press New York 387 392
203. D.M. Maxwell K.M. Brecht B.P. Doctor A.D. Wolfe Comparison of antidote protection against soman by pyridostigmine, HI-6, and acetylcholinesterase J. Pharmacol. Exp. Therap 264 1993 1085 1089
204. D.M. Maxwell D.E. Lenz W.A. Groff A. Kaminskis H.L. Froehlich The effect of blood flow and detoxification on in vivo cholinesterase inhibition by soman in rats Toxicol. Appl. Pharmacol 88 1987 66 76
205. J.H. McDonough Animal models of nerve agent intoxication and treatment of human nerve agent casualties: Identification of key variables for immediate therapy The meeting of NATO TG 004 Task Group on Prophylaxis and Therapy of Chemical Agents. 4–7 November 2002, Oslo, Norway 2002
206. J.H. McDonough J. McMonagle T. Copeland D. Zoeffel T.M. Shih Comparative evaluation of benzodiazepines for control of soman-induced seizures Arch. Toxicol 73 1999 473 478
207. J.H. McDonough J. McMonagle M. Gonzales T. Rowland T.-M. Shih Studies on anticonvulsants against nerve agent-induced seizures The meeting of NATO TG 004 Task Group on Prophylaxis and Therapy of Chemical Agents. 4–7 November 2002, Oslo, Norway 2002
208. M. McKinney J.H. Miller F. Yamada W. Tuckmantel A.P. Kozikowski Potencies and stereoselectivities of enantiomers of huperzine A for inhibition of rat cortical acetylcholinesterase Eur. J. Pharmacol 203 1991 303 305
209. Y. Meshulam G. Cohen S. Chapman D. Alkalai A. Levy Prophylaxis against organophosphate poisoning by sustained release of scopolamine and physostigmine J. Appl. Toxicol 21 Suppl. 1 2001 S75 S78
210. R.L. Metcalf Historical perspective of organophosphorus ester-induced delayed neurotoxicity Neurotoxicology 3 1982 269 284
211. H. Michalek A. Meneguz G.M. Bisso Molecular forms of rat brain acetylcholinesterase in DFP intoxication and subsequent recovery Neurobehav. Toxicol. Teratol 3 1981 303 312
212. H.O. Michel An electrometric method for the determination of red blood cell and plasma cholinesterase activity J. Lab. Clin. Med 34 1949 1564 1568
213. J.K. Miller D.E. Lenz Development of an immunoassay for diagnosis of exposure to toxic organophosphorus compounds J. Appl. Toxicol 21 2001 S23 S26
214. R. Molphy M. Ratthus Organic phosphorus poisoning and therapy Med. J. Austr 2 1964 337 340
215. D.H. Moore Bioscavengers as antidotes for organophosphorus (OP) agents “Proceedings of the 2nd CB Medical Treatment Symposium, 7–12 July 1996,” 1996 Spiez Switzerland 330 349
216. H. Morita T. Yanagisawa M. Nakajima M. Shimizu H. Hirabayashi H. Okudera M. Nohara Y. Midorikawa S. Mimura Sarin poisoning in Matsumoto, Japan Lancet 346 1995 290 293
217. N.B. Munro K.R. Ambrose A.P. Watson Toxicity of the organophosphate chemical warfare agents GA, GB, VX: Implications for public protection Environ. Health Perspect 102 1994 18 38
218. D.K. Myers Cholinesterase. VII. Determination of the molar concentration of pseudocholinesterase in serum Biochem. J 51 1952 303 311
219. T. Myhrer S. Enger P. Aas Soman-induced seizures in rats: Possible treatment and prophylaxis K. Laihia “Symposium Proceedings, NBC 2003” 2003 Jyvaskyla Finland 136 137
220. T. Myhrer S. Enger P. Aas Soman-induced seizures in rats: Possible treatment and prophylaxis The meeting of NATO TG 004 Task Group on Prophylaxis and Therapy of Chemical Agents. 4–7 November 2002, Oslo, Norway 2002
221. M. Nagao T. Takatori Y. Matsuda M. Nakajima H. Iwase K. Iwadare Definitive evidence for the acute sarin poisoning in diagnosis in the Tokyo subway Toxicol. Appl. Pharmacol 144 1997 198 203
222. T. Namba Cholinesterase inhibition by organophosphorus compounds and its clinical effects Bull. WHO 44 1971 289 307
223. T. Namba C.T. Nolte J. Jackrel D. Grob Poisoning due to organophosphate insecticides Am. J. Med 50 1971 475 492
224. L. Navratil J. Bajgar Relationship between plasma BuChE activity total cholesterolaemia (in Czech) Biochem. Clin. Bohemoslov 16 1987 117 121
225. M. Nenner Simultaneous determination of acetylcholinesterase ⧸EC 3.1.1.7⧸ activity in the whole blood, plasma, and erythrocytes with the automatic titrator Z. klin. Chem. Klin. Biochem 8 1970 537 540
226. D. Noort H.P. Benschop L.P.A. de Jong Methods for retrospective detection of exposure to toxic scheduled chemicals: An overview Voj. Zdrav. Listy 70 2001 14 17
227. D. Noort A.G. Hulst D.H.J.M. Plattenburg M. Polhuijs H.P. Benschop Quantitative analysis of O-isopropyl methylphosphonic acid in serum samples of Japanese citizens allegedly exposed to sarin: Estimation of internal dose Arch. Toxicol 72 1998 671 675
228. D. Noort H.P. Benschop R.M. Black Biomonitoring of exposure to chemical warfare agents: A review Toxicol. Appl. Pharmacol 184 2002 116 126
229. N. Ogane E. Giacobini E. Messamore Preferential inhibition of acetylcholinesterase molecular forms in rat brain J. Neurochem 17 1992 489 495
230. S. Ohtomi M. Takase F. Kunagoi A clinical experience in Japan Self Defence Force (JSDF) Central Hospital Intern. Rev. Armed Force Med. Serv 69 1996 97 102
231. J. Patocka J. Bajgar J. Bielavsky J. Fusek Kinetics of inhibition of cholinesterase by 1,2,3, 4-tetrahydro-9-aminoacridine Coll. Czechoslov. Chem. Commun 41 1976 816 824
232. J. Patocka Huperzine A—An interesting anticholinesterase compound from the Chinese herbal medicine Acta Med.(Hradec Kralove) 41 1998 155 157
233. J. Patocka J. Bajgar Affinity of human brain acetylcholinesterase to some organophosphates and carbamates J. Neurochem 18 1971 2545 2546
234. J. Patocka J. Bajgar J. Bielavsky Kinetics of hydrolysis of acetylthiocholine by oximes Coll. Czechoslov. Chem. Commun 38 1973 3685 3693
235. J. Patocka A. Jakl J. Bajgar J. Fusek Efficacy of various pretreatment and therapy regimens against soman lethality in mice Sbor. Ved. Pr. LFUK(Hradec Kralove) 34 1991 243 247
236. J. Patocka J. Kassa Huperzine A—Prospective prophylactic antidote against organophosphate warfare agent poisoning ASA Newslett 99–2 1999 16 19
237. J. Patocka Effect of pyridostigmine and syntostigmine pretreatment on the inhibition of acetylcholinesterase by O-pinacolyl-methylphosphonofluoridate In vitro experiments with rat tissues Biomed. Biochim. Acta 48 1989 715 720
238. R.H. Perry I.D. Wilson M.J. Bober J.R. Atack G. Blessed B.E. Tomlinson E.K. Perry Plasma and erythrocyte acetylcholinesterase in senile dementia of Alzheimer type Lancet 1 1982 174 175
239. I. Petrova J. Bielavsky An overview of syntheses of cholinesterase reactivators from 1980 to 1992 Voj. Zdrav. Listy (in Czech) 70 2001 63 73
240. M. Polhuis J.P. Langenberg H.P. Benschop A new method to detect organophosphate exposure: Serum analysis of victims of Japanese terrorists “m-CB Medical Treatment Symposium, 26–30 May 1997, Hradec Kralove,” 1997 25 [Abstracts].
241. M. Polhuijs J.P. Langenberg H.P. Benschop New method for retrospective detection of exposure to organophosphorus anticholinesterases: Application to alleged sarin victims of Japanese terrorists Toxicol. Appl. Pharmacol 146 1997 156 161
242. Z. Radic E. Reiner P. Taylor Role of the peripheral anionic site on acetylcholinesterase: Inhibition by substrates and coumarin derivatives Mol. Pharmacol 39 1991 98 104
243. Z. Rakonczay Cholinesterase and its molecular forms in pathological states Progr. Neurobiol 31 1988 311 330
244. Z. Rakonczay H. Papp Effect of chronic metrifonate treatment on cholinergic enzymes at the blood–brain barrier Neurochem. Int 39 2001 19 24
245. L. Raveh Y. Segall H. Leader N. Rothschild D. Levanon Y. Henis Y. Ashani Protection against tabun toxicity in mice by prophylaxis with an enzyme hydrolyzing organophosphate esters Biochem. Pharmacol 44 1992 397 400
246. M.L. Raves M. Harel Y.P. Pang I. Silman A.P. Kozikowski J.L. Sussman Structure of AChE complexed with the nootropic alkaloid (−) huperzine A Nat. Struct. Biol 4 1997 57 63
247. F. Reiner V. Simeon-Rudolf Cholinesterase: Substrate inhibition and substrate activation Pflugers Arch.-Eur. J. Physiol 440 2000 R118 R120
248. T.L. Rosenberry W.D. Mallender P.J. Thomas T. Szegletes A steric blockade model for inhibition of acetylcholinesterase by peripheral site ligands and substrate Chem. Biol. Interact 119–120 1999 85 97
249. J.S. Rotenberg J. Newmark Nerve attacks on children: Diagnosis and management Pediatrics 112 2003 648 658
250. C.G. Rousseaux A.K. Dua Pharmacology of HI-6, an H series oxime Can. J. Physiol. Pharmacol 67 1989 1183 1189
251. C. Rubin E. Esteban S. Kieszak R.H. Hill B. Dunlop R. Yacovac J. Trottier K. Boylan T. Tomasewski K. Pearce Assessment of human exposure and human health effects after indoor application of methyl parathion in Lorain County, Ohio, 1995–1996 Environ. Hlth Persp 110 2002 1047 1051
252. S. Rump M. Kowalczyk O. Antkowiak E. Gidynska E. Galecka Use and risks of anticonvulsant therapy in nerve agents poisoning in combat conditions Voj. Zdrav. Listy 70 2001 26 29
253. K. Sakurada K. Matsubara K. Shimizu H. Shiono Y. Seto K. Tsuge M. Yoshino I. Sakai H. Mukoyama T. Takatori Pralidoxime iodide (2-PAM) penetrates across the blood–brain barrier Neurochem. Res 28 2003 1401 1407
254. I. Samnaliev Efficacy of biperiden and HI-6 as a prophylactic combination against convulsions produced by a highly toxic organophosphorus compound Voj. Zdrav. Listy 70 2001 30 34
255. I. Samnaliev D. Draganov C. Dishovski Cholinesterase reactivators as prophylactics against OP intoxication “m-CB Medical Treatment Symposium, 26–30 May 1997, Hradec Kralove,” 1997 27 28 [Abstract].
256. M. Sasaki An ultra-micro assay of serum cholinesterase with m-nitrophenol indicator Rinsko Byori 12 1964 555 558
257. A. Saxena C. Luo R. Bansal W. Sun M.G. Clark D.E. Lenz Y. Ashani B.P. Doctor Scavenger protection against organophosphate agents by human serum butyrylcholinesterase The meeting of NATO TG 004 Task Group on Prophylaxis and Therapy of Chemical Agents. 4–7 November 2002, Oslo, Norway 2002
258. A. Saxena D.M. Maxwell D.M. Quinn Z. Radic P. Taylor B.P. Doctor Mutant acetylcholinesterases as potential detoxification agents for organophosphate poisoning Biochem. Pharmacol 54 1997 269 274
259. A. Saxena N. Qian I.M. Kovach A.P. Kozikowski Y.P. Pang D.C. Vellom Z. Radic D. Quinn P. Taylor B.P. Doctor Identification of amino acid residues involved in the binding of huperzine A to cholinesterases Protein Sci 3 1994 1770 1778
260. A. Saxena A.M.G. Redman X. Jiang O. Lockridge B.P. Doctor Differences in active-site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase Chem. Biol. Interact 119–120 1999 61 69
261. L. Sevelova J. Bajgar J. Fusek A. Saxena B.P. Doctor Inhalation intoxication with sarin in rats: Effect of pretreatment with butyrylcholinesterase 22nd Xenobiochemical Symposium, 9–11 June 2003, Smolenice, Slovakia 2003 174 175 [Abstracts].
262. L. Sevelova J. Vachek Effect of methoxime combined with anticholinergic, anticonvulsant, or anti-HCN drugs in tabun-poisoned mice Acta med. (Hradec Karalove) 46 2003 109 112
263. S. Shapira T. Kadar G. Cohen S. Chapman L. Raveh Effects of CBDP and MEPQ on the toxicity and distribution of ⧸H3⧸-soman in mice Arch. Toxicol 64 1990 663 668
264. T.M. Shih D.M. Penetar J.H. McDonough J.A. Romano J.M. King Age-related differences in soman toxicity and in blood and regional cholinesterase activity Brain Res. Bull 24 1990 429 436
265. T.M. Shih S.M. Duniho J.H. McDonough Control of nerve agent-induced seizures is critical for neuroprotection and survival Toxicol. Appl. Pharmacol 188 2003 69 80
266. T.M. Shih T.A. Koviak B.R. Capacio Anticonvulsants for poisoning by the organophosphorus compound soman—Pharmacological mechanisms Neurosci. Behav. Rev 15 1991 349 362
267. T.M. Shih J.H. Mc Donough Neuropharmacological mechanisms in soman-induced seizures J. Appl. Toxicol 17 1997 255 264
268. T.M. Shih J.H. McDonough I. Koplovitz Anticonvulsants for soman-induced seizure activity J. Biomed. Sci 6 1999 86 96
269. T.-M. Shih Ch.E. Whalley J.J. Valdes A comparison of cholinergic effects of HI-6 and pralidoxime-2-chloride (2-PAM) in soman poisoning Toxicol. Lett 55 1991 131 147
270. F.R. Sidell W.A. Groff The reactivatability of cholinesterase inhibited by VX and sarin in man Toxicol. Appl. Pharmacol 27 1972 241 252
271. D.B. Siders J.G. Batsakis D.E. Stiles Serum cholinesterase activity. A colorimetric microassay and some clinical correlations Am. J. Clin. Pathol 50 1968 344 350
272. A. Silver “The Biology of Cholinesterases. Frontiers in Biology, Vol. 36” A. Neuberger E.L. Tatum 1974 North Holland Publ. Co Amsterdam, Oxford, New York,
273. K.A. Skau Mammalian acetylcholinesterase: Molecular forms Comp. Biochem. Physiol 83C 1986 225 227
274. D. Sket Efficacy of antidotes against soman poisoning in female physostigmine-protected rats Pharmacol. Toxicol 72 1993 25 30
275. F. Skopec J. Bajgar Anticholinesterase action of organophosphates: Importance of the liver Sbor. Ved. Pr. LFUK (Hradec Kralove) 36 1993 83 92
276. F. Skopec J. Bajgar J. Patocka Changes of acetylcholinesterase activity in different brain areas of the rat following head irradiation Radiobiol. Radiotherap 22 1981 631 634
277. Y. Solberg M. Belkin The role of excitotoxicity in organophopshporous nerve agents central poisoning TIPS 18 1997 183 185
278. H. Soreq A. Gnatt Y. Loewenstein L.F. Neville Excavations into the active site-gorge of cholinesterase TIBS 17 1992 353 358
279. M.P. Stojiljkovic M. Maksimovic D. Bokonjic V. Kilibarda V. Tadic B. Boskovic Adamantanes versus carbamates as prophylactic agents in soman-poisoned rats “Proceedings from the 6th CBW Protection Symposium, Stockholm, May 10–15 1998,” 1998 197 202
280. W.K. Summers I.V. Majkovski G.M. Marsch K. Tachiki A. Kling Oral tetrahydroaminoacridine in long-term treatment of senile dementia Alzheimer type N. Engl. J. Med 315 1986 1241 1245
281. M. Sungur M. Guven Intensive care management of organophosphate insecticide poisoning Crit. Care 5 2001 211 215
282. J.L. Sussmann M. Harel F. Frolow C. Oefner A. Goldman L. Toker I. Silman Atomic structure of acetylcholinesterase from Torpedo californica: A prototypic acetylcholine-binding protein Science 253 1991 872 874
283. R. Sweeney D. Maxwell A theoretical expression for the protection associated with stoichiometric and catalytic scavengers in a single compartment model of organophosphorus poisoning The meeting of NATO TG 004 Task Group on Prophylaxis and Therapy of Chemical Agents. 4–7 November 2002, Oslo, Norway 2002
284. B-G. Talbot D.R. Anderson L.W. Harris L.W. Zarbrough W.J. Lennox A comparison of in vivo and in vitro rates of ageing of soman-inhibited erythrocyte acetylcholinesterase in different animal species Drug Chem. Toxicol 11 1988 289 395
285. th ed. 1985 MacMillan New York 1 129
286. P. Taylor L. Wong Z. Radic I. Tsigelny R. Bruggemann N. Hosea H.A. Berman Analysis of cholinesterase inactivation and reactivation by systematic structural modification and enantiomeric selectivity Chem. Biol. Interact 119–120 1999 3 15
287. H. Thiermann L. Szinicz F. Eyer F. Worek P. Eyer N. Felgenhauer T. Zilker Modern strategies in therapy of organophosphate poisoning Toxicol. Lett 107 1999 233 239
288. H. Thiermann F. Worek L. Szinicz T. Zilker P. Eyer Acetylcholinesterase activity and muscle function in mouse diaphragm preparation and organophosphate patients The meeting of NATO TG 004 Task Group on Prophylaxis and Therapy of Chemical Agents. 4–7 November 2002, Oslo, Norway 2002
289. V. Tonkopii Structure and efficiency of carbamates as drugs for prophylaxis against OP poisoning K. Laihia “Symposium Proceedings, NBC 2003” 2003 Jyvaskyla Finland 140 141
290. V. Tonkopii Oxidative stress in the mechanism of organophosphates neurotoxicity Toxicol. Lett 144 Suppl. 1 2003 132
291. M.E. Traina L.A. Serpietri Changes in the levels and form of rat plasma cholinesterases during chronic diisopropylphosphorofluoridate intoxication Biochem. Pharmacol 33 1984 645 653
292. K. Tuovinen E. Kaliste-Korhonen F.M. Raushel O. Hanninen Success of pyridostigmine, physostigmine, and phosphotriesterase treatments in acute sarin intoxication Toxicology 134 1999 169 178
293. K. Tuovinen Comparison of pyridostigmine, physostigmine, heptylphysostigmine, and phosphotriesterase treatments in sarin intoxication “Supplementum Proceedings from the 6th CBW Protection Symposium, Stockholm, May 10–15 1998,” 1998 254
294. K. Tuovinen O. Hanninen Protection of mice against soman by pretreatment with eptastigmine and physostigmine Toxicology 139 1999 233 241
295. M. Uhlig H. Luppa Charakterisierung esterspaltender Enzyme des Gehirns mit Hilfe der Polyacrylamid-Gel-Elektrophorese Acta histochem Suppl. 15 1975 133 137
296. J. Vachek V. Gersl J. Fusek O. Krs F. Skopec J. Bajgar Toxicities of O-alkyl S-(2-dialkylaminoethyl) methyl phosphonothiolates (V-compounds) Acta Medica (Hradec Kralove) 39 1996 67 71
297. M.J. Van der Schans B.J. Lander H. van der Wiel J.P. Langenberg H.P. Benschop Toxicokinetics of the nerve agent (+)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration Toxicol. Appl. Pharmacol 191 2003 48 62
298. M.J. Van der Schans D. Noort A. Fidder C.E.A.M. Degenhardt H.P. Benschop J.P. Langenberg Retrospective detection of exposure to organophosphorus anticholinesterases: Fluoride reactivation and mass spectrometric analysis of phosphylated human butyrylcholinesterase The meeting of NATO TG 004 Task Group on Prophylaxis and Therapy of Chemical Agents. 4–7 November 2002, Oslo, Norway 2002
299. H.P.M. Van Helden T.J.H. Bueters Protective activity of adenosine receptor antagonists in the treatment of organophosphate poisoning TIPS 20 1999 438 441
300. H.P.M. Van Helden R.W. Busker B.C.P. Melchers P.L.B. Bruijnzeel Pharmacological effects of oximes: How relevant are they? Arch. Toxicol 70 1996 779 786
301. H.A. Van Lith A.C. Beynen Dietary cholesterol lowers the activity of butyrylcholinesterase (EC 3.1.1.8), but elevates that of esterase-1 (EC 3.1.1.1) in plasma of rats Brit. J. Nutr 70 1993 721 726
302. H.A. Van Lith L.F.M. van Zutphen A.C. Beynen Butyrylcholinesterase activity in plasma of rats and rabbits fed high-fat diets Comp. Biochem. Physiol 98A 1991 339 342
303. M.T. Volpe G.M. Bisso H. Michalek In vivo and in vitro effects of diisopropyl fluorophosphate and paraoxon on individual molecular forms of rats' brain acetylcholinesterase Neurochem. Res 15 1990 975–970
304. G. Voss K. Sachsse Red cell and plasma cholinesterase activities in microsamples of human and animal blood determined simultaneously by a modified acetylthiocholine⧸DTNB procedure Toxicol. Appl. Pharmacol 16 1970 764 772
305. T. Vuinac I. Bosan-Kilibarda V. Jasprica-Hrelec Aggressive atropinization and prolonged administration of oximes in the treatment of severe poisoning with organophosphorous compounds “Proceedings CBMTS—Industry II, The First Congress on Chemical and Biological Terrorism. Dubrovnik 21–27 April 2001,” 2001 198 201
306. K. Walter M. Muller M.F. Barkworth A.V. Niciecki F. Stanislaus Pharmakokinetics of physostigmine in man following a single application of a transdermal sytem Brit. J. Clin. Pharmacol 39 1995 59 63
307. C. Weise H.J. Kreienkamp R. Raba A. Pedak A. Aaviksaar F. Hucho Anionic subsites of the acetylcholinesterase from Torpedo californica: Affinity labelling with the cationic reagent N,N-dimethyl-2-phenyl-aziridium EMBO J 9 1990 3885 3888
308. A. Weissmann-Brenner A. David A. Vidan A. Hourvitz Organophosphate poisoning: A multihospital survey Isr. Med. Assoc. J 4 2002 573 576
309. M. Whittaker Plasma cholinesterase variants and the anaesthesist Anaesthesia 35 1980 174 197
310. D. Wilkinson Clinical experience with Donepezil (Aricept) in the UK J. Neural Transm 54 Suppl. 1998 311 315
311. G.D. Winter Cholinesterase activity determination in an automated analysis system Ann. NY Acad. Sci 87 1960 629 635
312. R.F. Witter Measurement of blood cholinesterase: A critical account of methods of estimating cholinesterase with reference to their usefulness and limitations under different conditions Arch. Environ. Health 6 1963 537 563
313. O.L. Wolthuis H.P.M. van Helden B.P.C. Melchers R.W. Busker D.M.G. Degroot Search for a therapy against soman-intoxication Neurosci. Neurobehav. Rev 18 1994 469 486
314. F. Worek C. Diepold P. Eyer Dimethylphgosphoryl-inhibited human cholinesterases: Inhibition, reactivation, and aging kinetics Arch. Toxicol 73 1999 7 14
315. F. Worek T. Kirchner M. Backer L. Szinicz Reactivation by various oximes of human erythrocyte acetylcholinesterase inhibited by different organophosphorus compounds Arch. Toxicol 70 1996 497 503
316. F. Worek U. Mast D. Kiderlen C. Diepold P. Eyer Improved determination of acetylcholinesterase activity in human whole blood Clin. Chim. Acta 288 1999 73 90
317. F. Worek G. Reiter P. Eyer L. Szinicz Reactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphates Arch. Toxicol 76 2002 523 529
318. F. Worek H. Thiermann K. Aumuller E. Wagner L. Szinicz In vitro models for the assessment of oxime efficacy in nerve agent poisoning: Reactivation kinetics of various oximes The meeting of NATO TG 004 Task Group on Prophylaxis and Therapy of Chemical Agents. 4–7 November 2002, Oslo, Norway 2002
319. F. Worek R. Widmann O. Knopff L. Szinicz Reactivating potency of obidoxime, pralidoxime, HI 6 and Hlo 7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds Arch. Toxicol 72 1998 237 243
320. D.W. Wyckoff J.E. Davies A. Barquet J.E. Davies Diagnostic and therapeutic problems of parathion poisonings Ann. Intern. Med 68 1968 875 881
321. K. Yokoyama S. Araki K. Murata M. Nishikitami T. Okomura S. Ishimatsu M. Takasu Chronic neurobehavioral and central autonomic nervous system effects in Tokyo subway sarin poisoning J. Physiol 92 1998 317 323
322. T. Yoshida Toxicological reconsideration of organophosphate poisoning in relation to the possible nerve-gas sarin-poison disaster which happened in Matsumoto-city, Nagano Jap. J. Toxicol. Environ. Hlth 40 1994 486 497
323. G.D. Young I. Koplovitz Acute toxicity of cyclohexylmethylphosphonofluoridate (CMPF) in rhesus-monkeys—Serum biochemical and hematological changes Arch. Toxicol 69 1995 379 383